{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:24:51Z","timestamp":1783441491482,"version":"3.54.6"},"reference-count":86,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cpcardiol.2018.09.003","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T05:48:01Z","timestamp":1537422481000},"page":"100396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Gender Identity, Hormone Therapy, and Cardiovascular Disease Risk"],"prefix":"10.1016","volume":"45","author":[{"given":"Claudia","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Rikhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0516-7988","authenticated-orcid":false,"given":"Tahir","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amara","family":"Fazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kolber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry E.","family":"Hurwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Schneiderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0001","series-title":"Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People","year":"2011"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0002","series-title":"Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People","author":"Deutsch","year":"2016"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0003","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.beem.2015.01.004","article-title":"Adolescents with gender dysphoria","volume":"29","author":"Cohen-Kettenis","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0004","doi-asserted-by":"crossref","first-page":"e63347","DOI":"10.1371\/journal.pone.0063347","article-title":"Sex differences in age-related cardiovascular mortality","volume":"8","author":"Mikkola","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/M17-0577","article-title":"Cardiovascular disease among transgender adults receiving hormone therapy: a narrative review","volume":"167","author":"Streed","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0006","series-title":"How Many Adults Identify as Transgender in the United States?","author":"Herman","year":"2016"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0007","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0008","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0009","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.01.027","article-title":"Sex differences in cardiovascular risk factors and disease prevention","volume":"241","author":"Appelman","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0010","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.mcna.2015.02.003","article-title":"Cardiovascular disease risk assessment and prevention: current guidelines and limitations","volume":"99","author":"Alagona","year":"2015","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0011","unstructured":"Centers for Disease Control and Prevention. HIV among transgender people: centers for disease control and prevention; 2017."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0012","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/phn.12309","article-title":"HIV risk perception, HIV knowledge, and sexual risk behaviors among transgender women in south Florida","volume":"34","author":"De Santis","year":"2017","journal-title":"Public Health Nurs"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0013","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","article-title":"Effects of cross-sex hormone treatment on transgender women and men","volume":"125","author":"Deutsch","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0014","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MED.0000000000000231","article-title":"Priorities for transgender medical and healthcare research","volume":"23","author":"Feldman","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.21037\/tau.2016.09.04","article-title":"Hormone therapy for transgender patients","volume":"5","author":"Unger","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0016","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.yhbeh.2013.02.020","article-title":"Gender identity development in adolescence","volume":"64","author":"Steensma","year":"2013","journal-title":"Horm. Behav."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2015.05.127","article-title":"Safety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenone","volume":"200","author":"Lainscak","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0018","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/and.12317","article-title":"Diagnosis of prolactinoma in two male-to-female transsexual subjects following high-dose cross-sex hormone therapy","volume":"47","author":"Cunha","year":"2015","journal-title":"Andrologia"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0019","doi-asserted-by":"crossref","DOI":"10.4158\/EP-2018-0101","article-title":"Prolactin levels do not rise among transgender women treated with estradiol and spironolactone","author":"Bisson","year":"2018","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2017.12","article-title":"The effects of oestrogens and their receptors on cardiometabolic health","volume":"13","author":"Morselli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0021","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1073\/pnas.96.12.7077","article-title":"Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta","volume":"96","author":"Makela","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0022","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mce.2014.02.001","article-title":"Endothelial estrogen receptor isoforms and cardiovascular disease","volume":"389","author":"Kim","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0023","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12265-009-9149-y","article-title":"Gender dimorphisms in progenitor and stem cell function in cardiovascular disease","volume":"3","author":"Herrmann","year":"2010","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0024","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/bcr424","article-title":"How does the estrogen receptor work","volume":"4","author":"Gross","year":"2002","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0025","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/JOE-14-0611","article-title":"Androgen receptor in human endothelial cells","volume":"224","author":"Torres-Estay","year":"2015","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0026","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/01.CIR.89.4.1501","article-title":"Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women","volume":"89","author":"Losordo","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0027","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on the cardiovascular system","volume":"340","author":"Mendelsohn","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0028","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-15-0518","article-title":"Androgen receptor (AR) in cardiovascular diseases","volume":"229","author":"Huang","year":"2016","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0029","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3345\/kjp.2015.58.1.1","article-title":"Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty","volume":"58","author":"Kim","year":"2015","journal-title":"Korean J. Pediatr."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0031","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11934-017-0688-5","article-title":"Approach to androgen deprivation in the prostate cancer patient with pre-existing cardiovascular disease","volume":"18","author":"Greiman","year":"2017","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0032","article-title":"Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0033","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0015-0282(16)57837-6","article-title":"Steroidal and nonsteroidal \"add-back\" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient","volume":"64","author":"Surrey","year":"1995","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0034","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/MOL.0000000000000022","article-title":"Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative","volume":"24","author":"Howard","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/WHE.14.64","article-title":"Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease","volume":"11","author":"Harvey","year":"2015","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0036","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.maturitas.2017.08.003","article-title":"Gaps, limitations and new insights on endogenous estrogen and follicle stimulating hormone as related to risk of cardiovascular disease in women traversing the menopause: a narrative review","volume":"104","author":"El Khoudary","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0037","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1573403X1103150515110749","article-title":"A review of the relationships between endogenous sex steroids and incident ischemic stroke and coronary heart disease events","volume":"11","author":"Kim","year":"2015","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0038","doi-asserted-by":"crossref","DOI":"10.1111\/bph.14160","article-title":"GPCRs in context: sexual dimorphism in the cardiovascular system","author":"Mouat","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0039","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/09513590902770149","article-title":"Long-term oral contraceptive treatment, metabolic syndrome and measures of cardiovascular risk in pre-menopausal women: National Health and Nutrition Examination Survey 1999-2004","volume":"25","author":"Hurwitz","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/IJWH.S38342","article-title":"Prescribing menopausal hormone therapy: an evidence-based approach","volume":"6","author":"Sood","year":"2014","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0041","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1743-6109.2012.02726.x","article-title":"Estrogens in men: clinical implications for sexual function and the treatment of testosterone deficiency","volume":"9","author":"Kacker","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0042","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1530\/eje.1.02126","article-title":"The effects of the aromatase inhibitor anastrozole on bone metabolism and cardiovascular risk indices in ovariectomized, androgen-treated female-to-male transsexuals","volume":"154","author":"Bunck","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0043","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-145-3-200608010-00005","article-title":"Endogenous sex hormones and cardiovascular disease incidence in men","volume":"145","author":"Arnlov","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0044","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2003-030313","article-title":"Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment","volume":"89","author":"Maffei","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0045","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1464-5491.2007.02304.x","article-title":"Oestradiol replacement treatment and glucose homeostasis in two men with congenital aromatase deficiency: evidence for a role of oestradiol and sex steroids imbalance on insulin sensitivity in men","volume":"24","author":"Rochira","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0046","doi-asserted-by":"crossref","first-page":"898","DOI":"10.21037\/tau.2016.10.02","article-title":"Testosterone replacement therapy and the heart: friend, foe or bystander","volume":"5","author":"Lopez","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0047","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/molehr\/gaq015","article-title":"Endothelial progenitor cells as a new cardiovascular risk factor in Klinefelter's syndrome","volume":"16","author":"Di Mambro","year":"2010","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0048","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000272","article-title":"Testosterone and the cardiovascular system: a comprehensive review of the clinical literature","volume":"2","author":"Oskui","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0049","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-6196(11)60964-6","article-title":"Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"82","author":"Haddad","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0002-9343(01)00833-6","article-title":"Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis","volume":"111","author":"Whitsel","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0051","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2265.2005.02339.x","article-title":"Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis","volume":"63","author":"Isidori","year":"2005","journal-title":"Clin. Endocrinol. (Oxf.)."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0052","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc10-1233","article-title":"Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES2 study)","volume":"34","author":"Jones","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0053","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis","volume":"95","author":"Fernandez-Balsells","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0054","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/13697137.2014.887669","article-title":"Androgens and cardiovascular disease in postmenopausal women: a systematic review","volume":"17","author":"Spoletini","year":"2014","journal-title":"Climacteric"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0055","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S2213-8587(15)00284-3","article-title":"Testosterone in women\u2013the clinical significance","volume":"3","author":"Davis","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0056","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/jcem.84.6.5824","article-title":"Endogenous androgens and carotid intimal-medial thickness in women","volume":"84","author":"Bernini","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0057","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/EJE-10-0307","article-title":"Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients","volume":"163","author":"Sievers","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0058","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0059","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/09513590.2012.664191","article-title":"Improvement of the lipid profile in post menopausal women who use estradiol and testosterone implants","volume":"28","author":"Britto","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0060","doi-asserted-by":"crossref","first-page":"E1287","DOI":"10.1210\/jc.2013-4160","article-title":"Testosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial","volume":"99","author":"Huang","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0061","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000337274","article-title":"Estradiol\/Testosterone imbalance: impact on coronary heart disease risk factors in postmenopausal women","volume":"121","author":"Dai","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0062","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-8587(17)30099-2","article-title":"Puberty suppression in transgender children and adolescents","volume":"5","author":"Mahfouda","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0063","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jpeds.2013.10.068","article-title":"Clinical management of youth with gender dysphoria in Vancouver","volume":"164","author":"Khatchadourian","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0064","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jadohealth.2015.07.009","article-title":"Treating transgender youth: pushing the dialogue forward","volume":"57","author":"Vance","year":"2015","journal-title":"J. Adolesc. Health."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0065","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jsxm.2016.05.004","article-title":"Efficacy and safety of gonadotropin-releasing hormone agonist treatment to suppress puberty in gender dysphoric adolescents","volume":"13","author":"Schagen","year":"2016","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0066","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2796.2007.01809.x","article-title":"The origins of the developmental origins theory","volume":"261","author":"Barker","year":"2007","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0067","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study","volume":"169","author":"Wierckx","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03632.x","article-title":"Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses","volume":"72","author":"Elamin","year":"2010","journal-title":"Clin. Endocrinol. (Oxf.)."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0069","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1530\/EJE-14-0011","article-title":"Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern","volume":"170","author":"Gooren","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0070","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0735-1097(97)00080-6","article-title":"Long-term estrogen therapy improves vascular function in male to female transsexuals","volume":"29","author":"New","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0071","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1447-0756.2011.01815.x","article-title":"Altered arterial stiffness in male-to-female trans-sexuals undergoing hormonal treatment","volume":"38","author":"Sharula","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0072","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in trans-sexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0073","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2015.08.007","article-title":"Acute and chronic psychological stress as risk factors for cardiovascular disease: insights gained from epidemiological, clinical and experimental studies","volume":"50","author":"Lagraauw","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0074","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2105\/AJPH.2013.301241","article-title":"Stigma, mental health, and resilience in an online sample of the US transgender population","volume":"103","author":"Bockting","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0075","series-title":"The Report of the 2015 U.S. Transgender Survey","author":"James","year":"2016"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0076","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/trgh.2015.0008","article-title":"A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals","volume":"1","author":"White Hughto","year":"2016","journal-title":"Transgend Health"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0077","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4158\/EP161438.OR","article-title":"Increased rates of smoking cessation observed among transgender women receiving hormone treatment","volume":"23","author":"Myers","year":"2017","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0078","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMp1702427","article-title":"The future of transgender coverage","volume":"376","author":"Baker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0079","doi-asserted-by":"crossref","first-page":"e1738","DOI":"10.1097\/GOX.0000000000001738","article-title":"Trends in gender-affirming surgery in insured patients in the United States","volume":"6","author":"Lane","year":"2018","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0080","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bcp.12339","article-title":"Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review","volume":"78","author":"De Vera","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0081","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.pcad.2013.09.012","article-title":"The role of exercise and physical activity in weight loss and maintenance","volume":"56","author":"Swift","year":"2014","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0082","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/HCO.0000000000000204","article-title":"Smoking cessation and the cardiovascular patient","volume":"30","author":"Prochaska","year":"2015","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0083","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4158\/EP13014.OR","article-title":"A simple curriculum content change increased medical student comfort with transgender medicine","volume":"19","author":"Safer","year":"2013","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0084","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11606-015-3529-6","article-title":"Societal implications of health insurance coverage for medically necessary services in the U.S. transgender population: a cost-effectiveness analysis","volume":"31","author":"Padula","year":"2016","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0085","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1542\/peds.2005-0538","article-title":"The histrelin implant: a novel treatment for central precocious puberty","volume":"116","author":"Hirsch","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.cpcardiol.2018.09.003_bib0086","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-8587(16)30319-9","article-title":"Oestrogen and anti-androgen therapy for transgender women","volume":"5","author":"Tangpricha","year":"2017","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280618301427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280618301427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:56:23Z","timestamp":1758938183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280618301427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0146280618301427"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2018.09.003","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gender Identity, Hormone Therapy, and Cardiovascular Disease Risk","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2018.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100396"}}